latenc
viral
reactiv
increas
frequenc
viral
reactiv
lowlevel
persist
replic
constant
viral
reactiv
increas
level
continu
viral
replic
end
high
level
continu
replic
see
figur
illustr
longterm
repeat
stimul
immun
system
particularli
cell
latent
persist
virus
believ
play
import
role
immun
senesc
review
discuss
recent
evid
indic
individu
effect
interplay
homeostat
forc
persist
virus
may
key
driver
tcell
age
human
topic
cover
recent
year
includ
entir
recent
issu
seminar
immunolog
deal
cell
reconstitut
therefor
discuss
abbrevi
manner
text
figur
tcell
cell
differenti
thymu
bonemarrow
precursor
export
secondari
lymphoid
organ
figur
rate
product
recent
thymic
emigr
rte
proport
total
thymic
mass
amount
total
thymic
cell
content
per
day
mice
naiv
cell
mani
naiv
cell
maintain
trophic
signal
interact
tcr
selfpeptidemhc
complex
figur
naiv
tcell
surviv
also
requir
common
cytokinereceptor
c
famili
member
review
figur
howev
cell
also
regularli
replac
rte
random
manner
ensur
divers
naiv
tcell
pool
gener
believ
ensur
optim
respons
new
previous
unencount
infecti
challeng
vivo
naiv
cell
display
low
spontan
known
homeostat
cycl
figur
homeostat
prolifer
greatli
increas
lymphopaen
condit
induc
irradi
chemotherapi
hiv
infect
tcell
sens
excess
space
like
respond
excess
unus
tri
fill
antigenindepend
homeostat
prolif
expans
hpe
unclear
whether
peptidemhc
c
cytokin
signal
provid
particular
cell
type
dendrit
cell
stromal
cell
fig
andor
whether
cell
resid
confin
anatom
locat
ensur
competit
prevent
accumul
mani
cell
shown
oppos
action
main
homeostat
role
like
product
expans
regulatori
cell
memori
compart
aris
naiv
cell
follow
encount
antigen
encount
gener
effector
hi
hi
lo
lo
lo
lo
well
memori
cell
latter
broadli
divid
central
memori
effector
memori
cell
central
memori
cell
undergo
self
renew
lack
phenotyp
associ
acut
chronic
activ
hi
hi
hi
hi
therefor
gain
optim
spectrum
effector
function
short
delay
contrast
effector
memori
cell
hi
lo
lo
lo
activ
abl
perform
immedi
effector
function
memori
cell
less
depend
contact
specif
peptidemhc
surviv
figur
cycl
selfrenew
vivo
threeto
fourfold
faster
naiv
cell
capabl
vigor
prolifer
lymphopaen
condit
mice
hpe
well
homeostat
memori
tcell
mainten
depend
absenc
figur
therefor
face
repeat
pathogen
challeng
homeostat
forc
must
balanc
antigendriven
expans
naiv
antigenspecif
cell
gener
effectorcel
popul
subsequ
contract
recruit
surviv
cell
memori
compart
simultan
preserv
tcell
repertoir
divers
combat
new
pathogen
enabl
vigor
recal
respons
reinfect
young
adult
mice
number
divers
peripher
cell
remark
similar
differ
mice
strain
suggest
clonal
expans
contract
must
tightli
regul
adulthood
review
howev
balanc
like
depend
stabl
naiv
tcell
pool
critic
depend
product
new
cell
thymu
also
absenc
manifest
pathogen
challeng
case
specificpathogenfre
spf
anim
tcell
homeostasi
regul
avail
respons
cell
environment
trophic
surviv
signal
precis
inform
role
cytokin
primarili
c
famili
selfpeptidemhc
complex
provid
import
partial
nonredund
signal
metabol
signal
also
like
role
less
well
understood
possibl
present
unknown
signal
pathway
may
also
regul
tcell
number
although
immun
senesc
affect
mani
aspect
innat
adapt
immun
defect
tcell
immun
best
document
mark
review
inde
elderli
individu
old
anim
restor
tcell
popul
balanc
number
alon
often
correl
improv
respons
antigen
pathogen
challeng
mention
agerel
chang
tcell
immun
occur
singlecel
popul
level
cellautonom
defect
involv
disrupt
signal
tcr
costimulatori
receptor
figur
chang
describ
detail
elsewher
discuss
instead
focu
set
ageassoci
chang
involv
disrupt
tcell
popul
balanc
figur
area
begin
understood
disrupt
result
four
partial
interrel
event
involut
thymu
declin
naiv
tcell
number
reduct
tcell
repertoir
divers
accumul
memori
cell
specif
persist
pathogen
also
known
memori
inflat
phenomena
potenti
reduc
reserv
cell
need
protect
new
pathogen
thymic
involut
cardin
manifest
reduct
tcell
output
thymu
begin
earli
one
year
birth
human
puberti
week
laboratori
mice
remain
incomplet
understood
part
develop
thymocyt
thymic
stroma
codepend
proper
thymic
function
depend
crosstalk
make
difficult
precis
dissect
issu
recent
studi
implic
defect
commit
haematopoiet
stem
cell
lymphoid
lineag
migrat
lymphoidrestrict
precursor
known
earli
tcell
progenitor
common
lymphoid
progenitor
thymu
figur
howev
exclud
possibl
defect
thymic
stromal
compon
figur
potenti
precipit
factor
includ
certainli
limit
sex
hormon
parallel
thymic
involut
mark
drop
number
rte
thymu
seem
produc
rte
proport
overal
cellular
even
late
senesc
thu
thymic
cellular
drop
tcell
output
exampl
mice
less
tenth
rte
present
young
adult
counterpart
thymic
involut
consequ
mark
progress
declin
naiv
tcell
product
put
heavi
stress
homeostat
mechan
need
maintain
naiv
tcell
compart
much
adulthood
senesc
elderli
individu
rte
reach
peripheri
face
condit
differ
younger
counterpart
fewer
naiv
cell
surviv
turnov
alter
fig
rte
particularli
phenotyp
seem
surviv
well
peripheri
old
anim
thu
sever
process
play
old
naiv
tcell
pool
first
naiv
tcell
pool
could
directli
diminish
cell
death
andor
lifelong
recruit
memori
pool
although
lack
quantit
data
discern
whether
two
may
import
second
naiv
tcell
pool
could
indirectli
affect
grow
pool
memori
cell
may
compet
naiv
cell
given
overlap
use
surviv
mainten
cytokin
two
tcell
pool
possibl
two
popul
wholli
independ
regul
particularli
later
life
initi
postul
final
naiv
cell
continu
deplet
consequ
lymphopaen
condit
gener
excess
surviv
mainten
cytokin
trigger
hpe
naiv
cell
hpe
eventu
induc
convers
mani
naiv
cell
memoryphenotyp
cell
convincingli
shown
sever
studi
believ
occur
rapid
prolifer
even
respons
cytokin
activ
differenti
program
cell
recent
obtain
evid
monkey
consist
mechan
found
homeostat
prolifer
naiv
cell
blood
age
rhesu
macaqu
invers
correl
number
proport
naiv
cell
anim
accompani
accumul
cell
rather
rapid
turnov
support
mechan
also
found
human
cell
togeth
mechan
reduc
tcell
product
increas
tcell
convers
memori
cell
accumul
memori
cell
due
lifelong
encount
new
pathogen
synerg
reduc
tcr
divers
old
individu
importantli
reduct
affect
even
otherwis
divers
tcell
subset
stress
power
antigenindepend
homeostat
forc
eventu
precipit
agerel
tcell
popul
dysbal
chang
old
individu
occur
backdrop
like
heavili
influenc
chang
cytokin
environ
well
accept
product
decreas
age
contrast
less
clear
whether
agerel
alter
level
express
function
receptor
differ
tcell
subset
analysi
hinder
difficulti
measur
relev
concentr
due
highli
local
mechan
action
understand
whether
chang
cytokin
contribut
agerel
defect
tcell
homeostasi
ad
interest
clear
therapeut
potenti
c
cytokin
lymphopoiesi
andor
peripher
expans
mainten
tcell
subset
howev
much
remain
understood
vivo
action
exogen
administ
cytokin
particularli
nonhuman
primat
human
clinic
studi
summari
age
associ
dramat
increas
proport
memori
cell
blood
concomit
equival
decreas
proport
circul
naiv
cell
initi
event
believ
set
stage
disrupt
tcell
popul
balanc
thymic
involut
loss
cell
renew
occur
earli
life
independ
pathogen
exposur
individu
antigen
experi
subsequ
howev
antigen
experi
modul
situat
potenti
critic
influenc
tcell
popul
balanc
age
evid
suggest
persist
pathogen
occupi
especi
promin
posit
regard
homeostat
chang
loss
tcell
product
homeostat
prolifer
respons
rel
tcell
lymphopaenia
appear
critic
influenc
tcell
age
laboratori
mice
kept
spf
condit
howev
pathogenexpos
mammal
studi
far
specif
pathogen
provid
anoth
perhap
domin
level
influenc
upon
pathogen
invas
cell
specif
epitop
pathogen
undergo
tremend
expans
one
cell
gener
effector
cell
pathogen
elimin
cell
elimin
apoptosi
remain
recruit
memori
tcell
pool
persist
long
period
time
even
life
figur
differ
situat
occur
pathogen
elimin
persist
pathogen
establish
latent
chronic
infect
box
two
type
infect
differ
level
stimul
provid
immun
system
replic
pathogen
establish
chronic
infect
never
truli
control
host
although
level
pathogen
blood
like
lower
measur
peak
acut
infect
pathogen
constantli
replic
maintain
set
point
pathogen
load
figur
therefor
cell
immun
system
includ
cell
constantli
system
stimul
pathogen
mani
case
pathogen
caus
chronic
diseas
last
year
often
poor
prognosi
part
exhaust
cell
suppos
control
chronic
infect
type
includ
caus
hiv
siv
simian
immunodefici
viru
hepat
c
viru
chronic
strain
lymphocyt
choriomening
viru
lcmv
coincid
age
part
normal
age
process
affect
major
old
popul
caus
clinic
manifest
direct
patholog
therefor
discuss
except
relev
parallel
function
consequ
chronic
infect
seen
cell
age
contrast
chronic
infect
latent
infect
pathogen
control
system
therefor
detect
blood
time
figur
rather
pathogen
find
nich
establish
latenc
exampl
hsv
establish
latent
infect
neuron
mostli
sensori
ganglia
innerv
site
viral
entri
remain
larg
dormant
regard
genom
replic
occasion
latent
viru
reactiv
time
may
may
system
local
detect
fig
cours
stimul
cell
mainli
memori
cell
forc
viru
back
latent
state
howev
intermitt
stimul
potenti
lead
expans
pathogenspecif
tcell
popul
fig
although
stimul
cell
local
latent
infect
repeat
like
continu
least
pathogenreact
cell
therefor
associ
massiv
exhaust
andor
delet
part
tcell
repertoir
case
chronic
virus
inde
rare
see
loss
immun
control
latent
viru
even
advanc
age
unless
concomit
immun
suppress
independ
age
correl
experiment
clinic
evid
link
latent
infect
expand
popul
cell
advanc
age
describ
given
consider
pathogen
like
maximum
impact
age
immun
system
highli
adapt
host
gener
manifest
diseas
ubiquit
abl
infect
popul
earli
birth
although
numer
human
pathogen
persist
primari
infect
steril
immun
includ
mycobacteria
helminth
pathogen
class
best
correspond
descript
herpesvirida
herpesvirus
infect
human
earli
age
mani
remain
host
life
host
sign
diseas
box
usual
establish
latenc
specif
cell
type
tissu
deploy
multipl
mechan
evad
innat
adapt
immun
system
therefor
exquisit
well
adapt
host
narrow
host
rang
hsv
ebv
cmv
probabl
promin
herpesvirus
link
expans
cell
elderli
human
among
cmv
stand
typifi
key
featur
herpesviru
famili
pertin
tcell
age
first
cmv
preval
vari
industri
countri
nearli
develop
countri
increas
preval
older
human
even
industri
countri
second
tcell
respons
cmv
unusu
broad
target
numer
viral
peptid
respons
also
display
unusu
featur
progress
longterm
expans
antigenspecif
memori
cell
dub
memori
inflat
inde
tcell
respons
individu
epitop
viru
reach
total
memori
tcell
compart
respons
epitop
human
estim
occupi
entir
memori
tcell
pool
final
pronounc
progress
respons
associ
accumul
dysfunct
cmvspecif
cell
well
shorter
lifespan
octogenarian
although
natur
link
associ
clear
present
interest
find
report
recent
hadrup
et
al
complex
respons
cmv
old
human
larg
tcell
clonal
expans
specif
immunodomin
cmv
peptid
seen
octogenerian
nonagenerian
swedish
popul
studi
tend
becom
progress
promin
age
howev
individu
surviv
old
age
exhibit
smaller
tcell
respons
cmv
even
show
loss
clonotyp
respond
viru
rais
possibl
surviv
old
age
centennerian
may
associ
immun
system
overtli
preoccupi
persist
pathogen
unfortun
longitudin
studi
relev
human
popul
invalu
provid
inform
immun
age
relev
physiolog
model
suffer
ethic
practic
constraint
prevent
definit
experiment
thu
remain
unclear
whether
latent
viru
caus
memori
inflat
whether
direct
stimul
relev
cell
indirect
action
via
type
interferon
mediat
innat
immun
secret
stimul
viru
combin
mechan
experi
show
cell
specif
viral
antigen
accumul
holtappel
karrer
wherea
other
sierro
correl
express
antigensprotein
latenc
would
suggest
express
earli
reactiv
andor
latenc
drive
process
inflat
remain
formal
proven
also
possibl
age
immun
system
may
ineffici
control
latent
viru
reactiv
gene
express
due
tcellintrins
defect
allow
prolong
persist
viral
antigen
stimul
alreadi
expand
ineffici
pool
virusspecif
cell
scenario
agerel
tcell
defect
could
primari
caus
accumul
via
posit
feedback
loop
although
presenc
latent
viral
infect
would
need
expos
final
unclear
whether
expand
cell
human
resembl
spontan
aris
tcell
clonal
expans
seen
mice
whether
depend
viral
antigen
surviv
prolifer
answer
question
develop
model
latent
viral
infect
old
mice
sought
mimic
human
situat
earli
infect
youth
persist
life
hsv
administ
local
system
young
mice
expans
contract
mainten
tcell
respons
follow
longitudin
manner
follow
intraocular
administr
observ
expect
expans
day
follow
contract
stabl
mainten
virusspecif
cell
blood
measur
use
mhc
class
tetram
set
point
memori
mainten
stabl
next
month
point
mice
bona
fide
old
observ
slow
progress
variabl
accumul
hsvspecif
cell
anim
show
accumul
mice
reach
level
similar
even
higher
seen
peak
acut
infect
expand
virusspecif
cell
central
memori
phenotyp
sign
acut
activ
moreov
continu
administr
antivir
drug
alter
cours
accumul
altogeth
observ
suggest
local
hsv
infect
viral
reactiv
repeat
antigen
stimul
minor
role
accumul
virusspecif
cell
rather
phenotyp
accumul
cell
central
memori
cell
rais
possibl
expand
cell
aris
consequ
homeostat
process
similar
drive
onset
spontan
tcell
clonal
expans
uninfect
mice
regard
spontan
aris
antigenindepend
tcell
clone
express
high
level
receptor
survivalpromot
c
cytokin
similar
featur
observ
hsvspecif
cell
accumul
age
model
local
hsv
infect
consist
idea
old
age
homeostat
disturb
rather
repeat
antigen
stimul
key
factor
onset
tcell
expans
model
local
infect
latent
viru
anoth
line
evid
support
view
come
recent
import
paper
woodland
colleagu
author
found
tcell
clone
specif
acut
respiratori
viru
sendai
viru
clear
youth
markedli
expand
old
age
absenc
sign
antigendriven
activ
confirm
result
differ
acut
viru
wnv
suggest
gener
phenomenon
spf
mice
cell
memori
pool
adequ
respons
cytokineoth
surviv
factor
select
becom
tcell
clonal
expans
regardless
antigen
specif
antigen
stimul
note
children
young
adult
often
mount
strong
anticmv
respons
inflat
occur
later
life
pronounc
abnorm
exclus
age
far
promin
elderli
would
consist
import
role
agerel
homeostat
disturb
although
direct
progeroid
influenc
cmv
exclud
differ
kinet
tcell
expans
previous
describ
reddehas
colleagu
subsequ
klenerman
colleagu
use
mous
model
cmv
infect
murin
cmv
mcmv
model
earli
accumul
mcmvspecif
effector
memori
cell
memori
inflat
seen
earli
month
primari
infect
accumul
match
exceed
level
antigenspecif
cell
seen
peak
primari
infect
rather
low
primari
cmv
infect
contrast
observ
use
hsv
model
studi
rais
possibl
mcmv
differ
fundament
abil
induc
memori
inflat
differ
dose
rout
paramet
may
account
fact
induc
memori
inflat
model
test
possibl
immun
adult
mice
intraperiton
thu
match
rout
use
mcmv
experi
experi
saw
earli
pronounc
memori
inflat
start
three
month
post
infect
lang
et
al
submit
cell
exhibit
phenotyp
distribut
typic
effector
memori
cell
blood
tissu
secondari
lymphoid
organ
memori
inflat
could
delay
prevent
use
antivir
drug
tcell
transfer
virusfre
virusinfect
host
show
formal
direct
viral
stimul
establish
latenc
reactiv
latenc
necessari
produc
memori
inflat
lang
et
al
submit
nevertheless
resolv
basic
mechan
involv
onset
mainten
memori
inflat
decis
experi
need
evalu
role
viral
antigen
virallyinduc
innat
immun
respons
factor
process
overal
question
still
remain
relat
evolut
memori
inflat
old
age
inflat
cell
retain
effectoreffector
memori
phenotyp
function
convert
central
memori
cell
perhap
signifi
homeostat
cytokin
factor
rather
antigen
stimul
may
import
advanc
age
similar
distinct
situat
observ
human
question
remain
answer
given
import
interest
field
answer
probabl
far
ahead
mention
chronic
infect
hiv
hcv
chronic
strain
lcmv
shown
lead
tcell
clonal
exhaust
discoveri
chronic
stimul
exhaust
cell
express
program
cell
death
molecul
may
role
dampen
signal
costimulatori
pathway
led
attempt
improv
tcell
function
block
signal
blockad
well
blockad
cytokin
often
associ
inhibit
type
immun
result
mark
revers
function
exhaust
cell
mice
two
marker
associ
exhaust
killercel
lectinlik
receptor
subfamili
g
member
naturalkillercel
marker
often
associ
low
prolif
abil
shown
hivinfect
subject
mark
replic
senesc
cell
like
undergo
apoptosi
vivo
studi
express
marker
correl
precis
function
exhaust
far
attempt
revers
exhaust
phenotyp
human
cell
use
blockad
met
far
modest
success
review
suggest
pathway
concept
exhaust
need
better
understood
human
nevertheless
key
question
whether
similar
molecular
function
chang
occur
age
latent
infect
sever
manuscript
describ
accumul
dysfunct
hypofunct
cell
termin
differenti
phenotyp
associ
human
age
cell
termin
differenti
phenotyp
share
part
phenotyp
effector
memori
cell
lo
lo
lo
lo
human
also
reexpress
normal
express
naiv
cell
moreov
therefor
term
effector
memori
reexpress
temra
cell
although
cell
stain
mhc
class
tetram
confirm
specif
viral
antigen
situat
show
impair
absent
vitro
prolifer
product
respons
antigen
agonist
tcrspecif
antibodi
variabl
reduc
secret
although
cytolyt
capac
intact
function
phenotyp
cell
age
individu
taken
indic
exhaust
cell
realli
exhaust
counterpart
similar
popul
observ
chronic
viral
infect
sever
observ
urg
caution
equat
cell
popul
first
typic
express
ligand
severalfold
lower
cell
respond
cmv
age
individu
compar
respond
chronic
infect
hiv
hcv
lang
jnz
unpublish
observ
second
similar
tcell
popul
nonhuman
primat
possibl
hyporespons
vitro
appear
turn
quit
vigor
vivo
measur
label
bromodeoxyuridin
like
vitro
condit
simpli
provid
replica
environ
allow
cell
accumul
age
third
mention
littl
clinic
evid
exhaust
tcell
popul
inde
allow
reactiv
latent
herpesvirus
suppos
control
protect
function
subset
rare
address
directli
case
prolif
capac
even
protect
effect
call
termin
differenti
andor
exhaust
cell
strong
inde
profound
immunosuppress
necessari
reveal
clinic
reactiv
herpesviru
infect
elderli
suggest
adequ
control
age
immun
system
fourth
one
mind
anoth
physiolog
possibl
cell
aris
memori
inflat
realli
allow
prolifer
inde
homeostat
standpoint
would
seem
econom
curtail
prolifer
alreadi
expand
popul
therefor
ensur
expand
memori
cell
remain
hypoprolif
would
eleg
way
reduc
expans
cell
cours
remain
possibl
cell
usurp
space
potenti
constrict
tcell
repertoir
need
respons
new
microbi
invas
shown
case
spontan
aris
antigenindepend
tcell
clonal
expans
spf
mice
anoth
possibl
recent
shown
true
adult
mice
persist
herpesvirus
crossprotect
bacteri
infect
via
innat
immun
mechan
one
wonder
whether
extend
old
anim
human
well
therefor
role
latent
persist
herpesvirus
immun
organism
age
remain
reward
problem
mechanist
dissect
forese
futur
mechan
lead
tcell
senesc
cellular
popul
level
becom
better
defin
along
approach
design
realist
treatment
prevent
treat
tcell
senesc
andor
amelior
consequ
briefli
mention
sever
approach
potenti
achiev
therapeut
goal
tcell
senesc
vaccin
forefront
fight
infecti
diseas
sever
centuri
remain
among
best
strategi
avail
problem
associ
vaccin
elderli
unfortun
numer
stem
defect
impair
primari
respons
age
immun
system
pathogen
liveattenu
vaccin
associ
high
rate
complic
elderli
sever
flumist
medimmun
inc
nasal
spray
influenza
viru
vaccin
attenu
live
yellow
fever
vaccin
recommend
popul
contrast
heatkil
fulli
attenu
vaccin
weaker
tend
elicit
best
moder
humor
tcell
respons
respons
heavili
compromis
elderli
therefor
estim
elderli
receiv
benefit
annual
vaccin
influenza
viru
modif
exist
vaccin
thu
need
improv
vaccin
outcom
howev
clear
whether
modif
primarili
act
antigenpres
cell
cell
element
innat
immun
system
possibl
agerel
defect
prove
univers
individu
necessit
sort
screen
evalu
need
type
therapi
remain
far
use
biomark
screen
clearli
tcell
reserv
fatal
deplet
vaccin
antigen
cell
stimul
modif
vaccin
unlik
afford
benefit
recipi
therefor
even
higher
imper
screen
select
individu
immun
reconstitut
primari
cours
action
unfortun
fare
much
better
regard
screen
tool
case
although
studi
use
immun
risk
phenotyp
measur
prognost
factor
longev
agerel
paramet
modal
intervent
global
divid
thymic
rejuven
improv
maintain
peripher
naiv
cell
recent
extens
review
recent
volum
seminar
immunolog
howev
like
true
antiag
intervent
realm
tcell
immun
need
aim
former
persist
virus
inde
key
precipit
immun
age
antivir
therapi
could
anoth
potenti
desir
intervent
idea
larg
hypothet
present
need
verif
small
anim
model
moreov
antivir
drug
avail
herpesvirus
efficaci
rare
absolut
side
effect
would
consid
could
recommend
elderli
pertin
note
goal
would
steril
immun
anyway
imposs
reach
antiherpesviru
drug
rather
keep
virus
frequent
reactiv
final
nutrit
intervent
calor
restrict
recent
shown
improv
product
mainten
function
naiv
cell
rhesu
macaqu
corrobor
prior
data
rodent
parlay
pharmacolog
treatment
could
power
way
enhanc
tcell
immun
elderli
recent
result
tell
us
persist
pathogen
probabl
import
contributor
immunolog
abnorm
seen
age
human
drive
expans
accumul
effector
memori
cell
howev
still
remain
seen
whether
decis
influenc
immun
defenc
extens
longev
answer
question
await
control
experi
appropri
anim
model
hand
result
rodent
well
nonhuman
primat
human
strongli
support
decis
role
homeostat
forc
shape
immun
system
old
individu
whether
influenc
pronounc
latent
infect
remain
seen
effect
experi
tcell
reconstitut
thymic
rejuven
presenc
absenc
latent
persist
infect
conduc
illumin
issu
critic
import
understand
immun
age
wish
thank
member
laboratori
stimul
discuss
particular
dr
luka
cicinsain
anna
lang
brian
rudd
andrew
townsend
help
illustr
also
wish
acknowledg
support
usph
award
core
nation
primat
research
center
award
rr
onprc
nation
institut
health
cellular
state
imbal
product
neutral
molecul
known
reactiv
oxygen
speci
ro
h
oh
hoo
superoxid
ro
product
normal
counter
sever
mechan
aim
maintain
cellular
macromolecul
reduc
state
superoxidemetabol
enzym
glutathion
vitamin
c
mechan
repair
consequ
ro
activ
includ
peroxid
lipid
protein
nucleic
acid
oxid
stress
ensu
neutral
repair
mechan
overwhelm
ro
product
pathway
rejoin
dna
strand
break
without
reli
signific
homolog
main
known
pathway
use
kuend
bind
complex
regul
dna
protein
kinas
pathway
often
use
mammalian
cell
repair
strand
break
caus
dnadamag
agent
enzym
use
strandjoin
step
v
j
recombin
common
cytokinereceptor
famili
famili
cytokin
receptor
receptor
complex
compos
two
three
subunit
one
subunit
common
cytokinereceptor
c
subset
cell
suppress
regulatori
activ
toward
effector
cell
immun
cell
subset
includ
cell
express
high
level
receptor
transcript
factor
forkhead
box
regulatori
tcell
popul
produc
regulatori
cytokin
suppress
function
effector
cell
immun
cell
absenc
dysfunct
regulatori
cell
associ
sever
autoimmun
antigenexperienc
cell
lack
immedi
effector
function
abl
mediat
rapid
recal
respons
virtu
quick
sustain
cell
divis
rapid
develop
effector
effector
memori
cell
restimul
antigen
central
memori
cell
retain
migratori
properti
naiv
cell
therefor
circul
secondari
lymphoid
organ
termin
differenti
cell
lack
lymphnod
home
receptor
express
receptor
enabl
home
inflam
tissu
effector
memori
cell
contain
perforin
exert
immedi
effector
function
without
need
differenti
thymu
reach
maxim
rel
weight
birth
depend
speci
absolut
weight
rate
tcell
product
increas
year
birth
human
puberti
specificpathogenfre
mice
influenc
incomplet
elucid
list
factor
includ
sex
hormon
agerel
involut
begin
thymu
becom
atroph
total
size
reduc
stromal
compart
replac
fibrou
fat
tissu
thymic
tcell
output
proport
reduc
nevertheless
known
residu
vestig
thymic
tissu
remain
capabl
produc
thymocyt
even
advanc
senesc
tcell
homeostasi
defin
mainten
rel
stabl
number
naiv
memori
cell
balanc
tcr
divers
well
abil
tcell
pool
restor
number
divers
prior
rest
state
acut
antigen
challeng
anim
mainli
rodent
kept
vivarium
condit
wherebi
increas
list
pathogen
exclud
erad
coloni
anim
maintain
absenc
known
chronic
latent
persist
pathogen
enabl
better
control
experiment
condit
relat
immun
infect
also
set
apart
anim
model
pathogenexpos
human
nonhuman
primat
whose
immun
system
constant
contact
infect
biotinyl
monomer
mhc
molecul
fold
specif
peptid
bind
groov
tetramer
fluoresc
label
streptavidin
molecul
tetram
bind
cell
express
tcr
specif
cognat
peptid
allow
direct
enumer
antigenspecif
cell
state
nonreact
precursor
lymphocyt
respond
persist
antigen
differenti
effector
cell
driven
state
function
exhaust
wherebi
cell
longer
product
engag
control
pathogen
end
result
clonal
exhaust
purg
immunerespons
repertoir
particular
specif
specif
brdu
thymidin
analogu
incorpor
dna
replic
allow
track
cell
divid
use
brduspecif
antibodi
flow
cytofluorometri
immun
risk
phenotyp
irp
set
empir
immun
system
mainli
tcell
measur
believ
correl
therefor
potenti
biomark
immun
senesc
irp
compon
involv
cell
reduc
naiv
tcell
level
reduc
age
invert
ratio
youth
less
age
accumul
cell
effector
memori
reduc
prolif
abil
reduc
product
presenc
cytomegaloviru
infect
potenti
size
tcell
pool
respond
trait
note
correl
residu
lifespan
andor
abil
respond
new
vaccin
infect
studi
verif
reliabl
biomark
age
across
dispar
human
popul
larg
prospect
studi
urgent
need
tcell
popul
chang
result
decreas
tcell
product
involut
thymu
critic
contribut
deplet
naiv
tcell
pool
naiv
tcell
pool
undergo
increas
homeostat
cycl
maintain
naiv
compart
increas
cycl
approxim
everi
month
mice
turn
homeostat
prolifer
divisionsmonth
level
seen
tcell
memori
pool
phenotyp
convers
naiv
cell
memori
phenotyp
cell
potenti
deplet
naiv
tcell
compart
condit
favor
disrupt
mainten
memori
compart
provid
impetu
gener
tcell
clonal
expans
young
thymu
produc
robust
number
divers
new
cell
infrequ
cycl
involut
age
thymu
produc
mani
fewer
naiv
cell
also
poorli
surviv
age
individu
b
known
agerel
alter
includ
alter
express
function
receptor
human
increas
turnov
naiv
cell
monkey
human
potenti
precipit
convers
memori
cell
b
process
would
also
support
format
antigenindepend
tcell
clonal
expans
chang
level
import
tcell
mainten
cytokin
well
known
increas
proinflammatori
cytokin
tumournecrosi
factor
chang
system
local
level
hormon
insulinlik
growth
factor
growth
hormon
ghrelin
leptin
could
also
play
role
although
yet
proven
infect
associ
immun
respons
case
kinet
activ
wane
innat
immun
kinet
infecti
viru
kinet
initi
primari
tcell
respons
essenti
key
differ
emerg
subsequ
caus
agent
acut
infect
elimin
tcell
memori
therefor
maintain
less
constant
low
level
contrast
b
latent
persist
pathogen
period
reactiv
wave
broken
line
provid
everi
time
activ
innat
immun
wave
dot
line
innat
immun
properti
memori
innat
cell
accumul
howev
memori
cell
accumul
follow
stimul
therefor
produc
memori
inflat
ascend
wavi
line
process
pronounc
cell
discret
cell
page
nat
rev
immunol
author
manuscript
avail
pmc
august
schemat
depict
rel
avail
therefor
exposur
cell
viral
antigen
cours
infect
differ
persist
virus
latent
virus
reach
fairli
high
antigen
level
cours
primari
infect
establish
latenc
reactiv
intermitt
differ
frequenc
cytomegaloviru
cmv
often
herp
simplex
viru
hsv
contrast
hiv
antigen
repres
chronic
persist
infect
present
high
level
initi
importantli
also
remain
high
level
blood
setpoint
infect
provid
cell
constant
stimul
eventu
exhaust
note
illustr
mostli
base
indirect
immunolog
paramet
cmv
hsv
rather
direct
identif
viru
viral
antigen
difficult
achiev
persist
phase
infect
page
nat
rev
immunol
author
manuscript
avail
pmc
august
